Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;7(7):1358-1374.
doi: 10.1038/s42255-025-01313-x. Epub 2025 Jun 26.

Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD

Affiliations

Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD

Wesley Huang et al. Nat Metab. 2025 Jul.

Abstract

Increased reactive oxygen species (ROS) levels are a hallmark of inflammatory bowel disease (IBD) and constitute a major mechanism of epithelial cell death. Approaches to broadly inhibit ROS have had limited efficacy in treating IBD. Here we show that lipid peroxidation contributes to the pathophysiology of IBD by promoting ferroptosis, an iron-dependent form of programmed cell death. Mechanistically, we provide evidence of heterocellular crosstalk between intestinal fibroblasts and epithelial cells. In IBD tissues and mouse models of chronic colitis, acyl-CoA synthetase long-chain family 4 (ACSL4) is overexpressed in fibroblasts. ACSL4 in fibroblasts reprograms lipid metabolism and mediates intestinal epithelial cell sensitivity to ferroptosis. In mouse models, overexpressing ACSL4 in fibroblasts results in increased intestinal epithelial ferroptosis and worsened colitis, while pharmacological inhibition or deletion of fibroblast ACSL4 ameliorates colitis. Our work provides a targeted approach to therapeutic antioxidant treatments for IBD.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Tavakoli P et al. A review of inflammatory bowel disease: a model of microbial, immune and neuropsychological integration. Public Health Rev. 42, 1603990 (2021). - PMC - PubMed
    1. Huang W, Aabed N & Shah YM Reactive oxygen species and ferroptosis at the nexus of inflammation and colon cancer. Antioxid. Redox Signal 39, 551–568 (2023). - PMC - PubMed
    1. Chen L et al. The antioxidant procyanidin reduces reactive oxygen species signaling in macrophages and ameliorates experimental colitis in mice. Front. Immunol 8, 1910 (2017). - PMC - PubMed
    1. Ananthakrishnan AN et al. Statin use is associated with reduced risk of colorectal cancer in patients with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol 14, 973–979 (2016). - PMC - PubMed
    1. Moura FA et al. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biol. 6, 617–639 (2015). - PMC - PubMed

Grants and funding

LinkOut - more resources